(Q40843911)

24 September 2017

0 references

Pharmacologic treatment of sleep-disordered breathing (English)

1 reference

24 September 2017

1 reference

Hudgel DW

1

1 reference

24 September 2017

Thanakitcharu S

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

American Journal of Respiratory and Critical Care Medicine

24 September 2017

published in

1 reference

24 September 2017

volume

158

1 reference

24 September 2017

issue

3

1 reference

24 September 2017

page(s)

691-699

1 reference

Effects of medroxyprogesterone acetate in obstructive sleep apnea.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Progesterone therapy for sleep apnea syndrome evaluated by occlusion pressure responses to exogenous loading.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Effect of short-term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Medroxyprogesterone acetate and ethanol-induced exacerbation of obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

SEVERE DEPRESSION OF THE RESPIRATORY CENTER IN MYXEDEMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Obstructive sleep apnea in hypothyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

The relationship between sleep apnea syndrome and hypothyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Sleep apnea and hypothyroidism: mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Central apnea index decreases after prolonged treatment with acetazolamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Effect of metabolic acidosis upon sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Effects of acetazolamide in patients with the sleep apnoea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

The effects of aminophylline on sleep and sleep-disordered breathing in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Theophylline in obstructive sleep apnea. A double-blind evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Increased CSF opioid activity in sleep apnea syndrome. Regression after successful treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Nicotine: a different approach to treatment of obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Alteration in obstructive apnea pattern induced by changes in oxygen- and carbon-dioxide-inspired concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Treatment of refractory sleep apnea with supplemental carbon dioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Beneficial effect of inhaled CO2 in a patient with non-obstructive sleep apnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Sleep apnea: Treatment with protriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Protriptyline in the treatment of sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Protriptyline in obstructive sleep apnea: a double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

The effects of protriptyline in sleep-disordered breathing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Response of Obstructive Sleep Apnea to Fluoxetine and Protriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Preliminary clinical experience with imipramine HCl in the treatment of sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

Effect of Clonidine in Obstructive Sleep Apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

The effects of the GABA agonist, baclofen, on sleep and breathing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.3.9802019

10.1164/AJRCCM.158.3.9802019

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference